Contemporary epidemiology of chronic liver disease and cirrhosis
Background & Aims Accurate estimates for the contemporary burden of chronic liver disease
(CLD) are vital for setting clinical, research, and policy priorities. We aimed to review the …
(CLD) are vital for setting clinical, research, and policy priorities. We aimed to review the …
Chronic hepatitis B virus infection
Chronic hepatitis B virus infection is a global public health threat that causes considerable
liver-related morbidity and mortality. It is acquired at birth or later via person-to-person …
liver-related morbidity and mortality. It is acquired at birth or later via person-to-person …
Estimating the proportion of people with chronic hepatitis B virus infection eligible for hepatitis B antiviral treatment worldwide: a systematic review and meta-analysis
M Tan, AS Bhadoria, F Cui, A Tan… - The lancet …, 2021 - thelancet.com
Background In 2016, of the estimated 257 million people living with chronic hepatitis B virus
(HBV) infection worldwide, only a small proportion was diagnosed and treated. The …
(HBV) infection worldwide, only a small proportion was diagnosed and treated. The …
Molecular pathogenesis of cholangiocarcinoma
PL Labib, G Goodchild, SP Pereira - BMC cancer, 2019 - Springer
Background Cholangiocarcinomas are a heterogeneous group of malignancies arising from
a number of cells of origin along the biliary tree. Although most cases in Western countries …
a number of cells of origin along the biliary tree. Although most cases in Western countries …
[图书][B] Prevention of mother-to-child transmission of hepatitis B virus (HBV): Guidelines on antiviral prophylaxis in pregnancy
World Health Organization - 2020 - books.google.com
WHO estimates that in 2015, 257 million people were living with chronic hepatitis B virus
(HBV) infection worldwide, and that 900 000 had died from HBV infection, mostly as a result …
(HBV) infection worldwide, and that 900 000 had died from HBV infection, mostly as a result …
Human organs-on-chips for virology
While conventional in vitro culture systems and animal models have been used to study the
pathogenesis of viral infections and to facilitate development of vaccines and therapeutics …
pathogenesis of viral infections and to facilitate development of vaccines and therapeutics …
[PDF][PDF] Progress report on HIV, viral hepatitis and sexually transmitted infections 2019: accountability for the global health sector strategies, 2016–2021
World Health Organization - 2019 - apps.who.int
Progress report on HIV, viral hepatitis and sexually transmitted infections, 2019 Page 1 Progress
report on HIV, viral hepatitis and sexually transmitted infections, 2019 Accountability for the global …
report on HIV, viral hepatitis and sexually transmitted infections, 2019 Accountability for the global …
APASL guidance on stopping nucleos (t) ide analogues in chronic hepatitis B patients
Chronic hepatitis B virus (HBV) infection is currently incurable. Long-term treatment with
potent and safe nucleos (t) ide analogs (NAs) can reduce hepatocellular carcinoma (HCC) …
potent and safe nucleos (t) ide analogs (NAs) can reduce hepatocellular carcinoma (HCC) …
A global investment framework for the elimination of hepatitis B
Background & Aims More than 292 million people are living with hepatitis B worldwide and
are at risk of death from cirrhosis and liver cancer. The World Health Organization (WHO) …
are at risk of death from cirrhosis and liver cancer. The World Health Organization (WHO) …
Microfluidic organs-on-a-chip for modeling human infectious diseases
Conspectus Infectious diseases present tremendous challenges to human progress and
public health. The emergence of severe acute respiratory syndrome coronavirus 2 (SARS …
public health. The emergence of severe acute respiratory syndrome coronavirus 2 (SARS …